Fill & finish, packaging

Source wikipedia

update

Trump vows to bring drug production back to US

By Gareth Macdonald

President elect Donald Trump has said he will bring drug manufacturing back to the US and introduce bidding measures to cut the amount the country spends on medicines. 

iStock/Melpomenem

Packaging design: how to ensure successful patient outcomes

By Melissa Fassbender

As holidays shoppers wrap up their presents with ribbons and bows, Outsourcing-Pharma.com reviews how contract pharmaceutical packaging companies help ensure successful patient outcomes with iterative design.

Custom Pharma Services offers services ranging from clinical to commercial. (Image: iStock/KCHL)

CDMO Custom Pharma Services expands operations

By Melissa Fassbender

The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.

(Image: Impax Laboratories, Inc.)

Impax recalls tablets due to incorrect labeling

By Melissa Fassbender

Impax Laboratories has issued a voluntary recall for one lot of its Lamotrigine Orally Disintegrating Tablet due to incorrect labeling of its blister packs.

(Image: iStock)

CRO Velesco Pharma adds compound management services

By Melissa Fassbender

The contract research organization (CRO) Velesco Pharma has opened a new laboratory in its Plymouth, MI-based facility to support an increased demand for materials management.

Partners Group plans to work with PCI's management team to add more specialized offerings. (Image: iStock/RomoloTavani)

PCI Pharma Services' new owners focused on growth

By Melissa Fassbender

Partners Group, a private markets investment manager, has agreed to acquire global pharmaceutical services provider PCI Pharma Services citing “trends towards outsourcing.”

Vistapharm manufacturing facility in Largo, Florida

Packaging defect prompts VistaPharm oxy recall

By Gareth Macdonald

VistaPharm has recalled thousands of cases of generic oxycodone as a result of a defect that allowed the powerful painkiller to leak out of the packaging.